Fiabilidad de los predictores clínicos y de la biopsia de arteria ...

More documents

Recommendations

Info

Fiabilidad de los predictores clínicos y de la biopsia de arteria temporal en el diagnóstico de la arteritis de células gigantes Joan Brunsó Casellas 227- Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebocontrolled trial. Ann Intern Med. 2001;134:106-114. 228- Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Schousboe J, Cohen P, et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002;46:1309-1318. 229- Cantini F, Niccoli L, Salvarani C, Padula A, Olivieri I. Treatment of longstanding active giant cell arteritis with infliximab: report of four cases. Arthritis Rheum. 2001;44:2933-5. 230- Cantini F, Niccoli L, Nannini C, Bertoni M, Salvarani C. Diagnosis and treatment of giant cell arteritis. Drug Aging. 2008; 25(4): 281-297. 231- Martinez-Taboada VM, Rodriguez-Valverde V, Carreno L, Lopez-Longo J, Figueroa M, Belzunegui J, et al. A doublé-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects. Ann Rheum Dis. 2008; 67(5):625-630. 232- Hoffman GS, Cid M, Rendt-Zagar K, Merkel P, Weyand C, Stone J, et al.Infliximab for manintenance of glucocorticosteroid-induced remission of giant cell arteritis. Ann Intern Med. 2007; 146:621-630. 233- Sailler L, Carreiro M, Ollier S, Juchet H, Delobel P, Ferrand D, et al. Noncomplicated Horton's disease: initial treatment with methylprednisolone 500 mg/day bolus for three days followed by 20 mg/day prednisone-equivalent: evaluation of 15 patients. Rev Med Interne. 2001;22:1032-8. 234- Mazlumzadeh M, Calamia KT, Matteson EL. High dose pulse intravenous glucocorticoid infusion as the initial treatment of giant cell arteritis. Arthritis Rheum. 2004;50:269. 235- Spiera RF, Kupersmith M, Paget S, et al.: Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al. Arthritis Rheum .2003; 48:1158-1170. 236- Hunder GG, Sheps SG, Allen GL. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med .1975; 82:613-8. 237- Bengtsson BA, Malmvall BE. An alternate-day corticosteroid regimen in maintenance therapy of giant cell arteritis. Acta Med Scand .1981; 209:347- 350. 238- Ruegsegger P, Medici TC, Anliker M. Corticosteroid-induced bone loss. A 166
Fiabilidad de los predictores clínicos y de la biopsia de arteria temporal en el diagnóstico de la arteritis de células gigantes Joan Brunsó Casellas longitudinal study of alternate-day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol. 1983; 25:615-620. 239- Salvarani C, Canini F, Boiardi L, Hunder GG. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol. 2003;21(32):23-8. 240- Brack A, Rittner HL, Younge CK. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras J Clin Invest .1997; 99:2842-2850. 241- Schmidt D, Vaith P, Hetzel A. Prevention of serious ophthalmic and cerebral complications in temporal arteritis? Clin Exp Rheumatol. 2000; 20:61-3. 242- Gonzalez-Gay M A, Garcia-Porrua C, Llorca J. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000; 79: 283 –292. 243- Loddenkemper T ,Sharma P , tzan I , Plant GT . Risk factors for early visual deterioration in temporal arteritis. J Neurol neurosurg psychiatry. 2007;78(11): 1255-9. 244- Frauman AG. An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug React Toxicol Rev. 1996;15:203-6. 245- American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid induced osteoporosis update. Arthritis Rheum. 2001;44:1496-1503. 246- Foroozan R, Deramo VA, Buono LM. Recovery of visual function in patients with biopsy-proven giant cell arteritis. Ophthalmology. 2003;110:539-542. 247- Nesher G, Berkun Y, Mates M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum. 2004;50:1332- 7. 167
Page 1 and 2:
Fiabilidad de los predictores clín
Page 3:
A mi madre, en su recuerdo. A mi pa
Page 6 and 7:
Page 8 and 9:
Page 10 and 11:
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Íntima: Fiabilidad de los predicto
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
PCR Fiabilidad de los predictores c
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117: Fiabilidad de los predictores clín
Page 182: Fiabilidad de los predictores clín
show all

Fiabilidad de los predictores clínicos y de la biopsia de arteria ...

Create successful ePaper yourself

Delete template?

Save as template?